Baidu
map

2019 GINA指南:成人和青少年难治性严重哮喘的诊断和管理(袖珍版)

2019-04-12 全球哮喘防治创议 GINA官网

2019年4月,全球哮喘防治创议(GINA)发布了成人和青少年难治性严重哮喘的诊断和管理修真指南,文章的主要目的是总结当前关于青少年和成人难治性严重哮喘的识别,评估管理提供专家指导建议。

中文标题:

2019 GINA指南:成人和青少年难治性严重哮喘的诊断和管理(袖珍版)

英文标题:

GINA DIFFICULT-TO-TREAT & SEVERE ASTHMA in adolescent and adult patients Diagnosis and Management

发布机构:

全球哮喘防治创议

发布日期:

2019-04-12

简要介绍:

2019年4月,全球哮喘防治创议(GINA)发布了成人和青少年难治性严重哮喘的诊断和管理修真指南,文章的主要目的是总结当前关于青少年和成人难治性严重哮喘的识别,评估管理提供专家指导建议。 

拓展指南:哮喘相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 GINA指南:成人和青少年难治性严重哮喘的诊断和管理(袖珍版))] GetToolGuiderByIdResponse(projectId=1, id=fba6f1c001e33521, title=2019 GINA指南:成人和青少年难治性严重哮喘的诊断和管理(袖珍版), enTitle=GINA DIFFICULT-TO-TREAT & SEVERE ASTHMA in adolescent and adult patients Diagnosis and Management, guiderFrom=GINA官网, authorId=null, author=, summary=2019年4月,全球哮喘防治创议(GINA)发布了成人和青少年难治性严重哮喘的诊断和管理修真指南,文章的主要目的是总结当前关于青少年和成人难治性严重哮喘的识别,评估管理提供专家指导建议。 , cover=, journalId=null, articlesId=null, associationId=208, associationName=全球哮喘防治创议, associationIntro=1993年,美国国立心肺血液研究所与世界卫生组织合作起草了全球哮喘管理和预防策略的报告,同时推行全球哮喘防治创议(GINA)。 GINA的目标:    提高哮喘作为一个全球性的公共卫生问题的认识。    提供诊断和治疗哮喘的关键性建议。    为不同健康需求、不同的健康服务机构和卫生资源提供相应的策略。    为全球社会指明具有特殊意义的研究领域。, copyright=0, guiderPublishedTime=Fri Apr 12 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年4月,全球哮喘防治创议(GINA)发布了成人和青少年难治性严重哮喘的诊断和管理修真指南,文章的主要目的是总结当前关于青少年和成人难治性严重哮喘的识别,评估管理提供专家指导建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>哮喘</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=843a81c001e331cc" title="2019 GINA 全球哮喘处理和预防策略(针对成人和5岁以上儿童)-袖珍指南" target=_blank>2019 GINA 全球哮喘处理和预防策略(针对成人和5岁以上儿童)-袖珍指南</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=808f01c0016e3823" title="支气管哮喘基层诊疗指南(2018年)" target=_blank>支气管哮喘基层诊疗指南(2018年)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=340d21c001659113" title="特殊健康状态儿童预防接种专家共识之二—支气管哮喘与预防接种" target=_blank>特殊健康状态儿童预防接种专家共识之二—支气管哮喘与预防接种</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=0506f1c001639e24" title="2018全球哮喘防治倡议哮喘指南解读" target=_blank>2018全球哮喘防治倡议哮喘指南解读</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=944ee1c00158220b" title="2018 专家最佳实践建议:支气管热成型术治疗严重哮喘" target=_blank>2018 专家最佳实践建议:支气管热成型术治疗严重哮喘</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E5%93%AE%E5%96%98" target=_blank>有关哮喘更多指南</a></ul>, tagList=[TagDto(tagId=89426, tagName=难治性严重哮喘)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7814, appHits=457, showAppHits=49, pcHits=4221, showPcHits=4292, likes=52, shares=21, comments=7, approvalStatus=1, publishedTime=Sun May 05 23:23:28 CST 2019, publishedTimeString=2019-04-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun May 05 23:23:28 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 13:06:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 GINA指南:成人和青少年难治性严重哮喘的诊断和管理(袖珍版))])
2019 GINA指南:成人和青少年难治性严重哮喘的诊断和管理(袖珍版)
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1220084, encodeId=72bf122008477, content=英文 看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83dd8166609, createdName=ms1000001987466727, createdTime=Mon May 16 19:22:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963713, encodeId=47ec963e13f8, content=没积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/05735cbd2c774b54b63d3351c859e96a/e3534dc2feb14208afd8fe5875b5980b.jpg, createdBy=48af5495416, createdName=ms7000001080466052, createdTime=Sat May 08 14:03:02 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963712, encodeId=0cf3963e12cb, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/05735cbd2c774b54b63d3351c859e96a/e3534dc2feb14208afd8fe5875b5980b.jpg, createdBy=48af5495416, createdName=ms7000001080466052, createdTime=Sat May 08 14:02:58 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909142, encodeId=6ac3909142bb, content=没有积分 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22475411922, createdName=ms9000001633000472, createdTime=Fri Dec 18 16:18:20 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914435, encodeId=c1869144356f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Thu Jan 07 16:25:46 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2022-05-16 ms1000001987466727

    英文 看不懂

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1220084, encodeId=72bf122008477, content=英文 看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83dd8166609, createdName=ms1000001987466727, createdTime=Mon May 16 19:22:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963713, encodeId=47ec963e13f8, content=没积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/05735cbd2c774b54b63d3351c859e96a/e3534dc2feb14208afd8fe5875b5980b.jpg, createdBy=48af5495416, createdName=ms7000001080466052, createdTime=Sat May 08 14:03:02 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963712, encodeId=0cf3963e12cb, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/05735cbd2c774b54b63d3351c859e96a/e3534dc2feb14208afd8fe5875b5980b.jpg, createdBy=48af5495416, createdName=ms7000001080466052, createdTime=Sat May 08 14:02:58 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909142, encodeId=6ac3909142bb, content=没有积分 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22475411922, createdName=ms9000001633000472, createdTime=Fri Dec 18 16:18:20 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914435, encodeId=c1869144356f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Thu Jan 07 16:25:46 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2021-05-08 ms7000001080466052

    没积分了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1220084, encodeId=72bf122008477, content=英文 看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83dd8166609, createdName=ms1000001987466727, createdTime=Mon May 16 19:22:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963713, encodeId=47ec963e13f8, content=没积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/05735cbd2c774b54b63d3351c859e96a/e3534dc2feb14208afd8fe5875b5980b.jpg, createdBy=48af5495416, createdName=ms7000001080466052, createdTime=Sat May 08 14:03:02 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963712, encodeId=0cf3963e12cb, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/05735cbd2c774b54b63d3351c859e96a/e3534dc2feb14208afd8fe5875b5980b.jpg, createdBy=48af5495416, createdName=ms7000001080466052, createdTime=Sat May 08 14:02:58 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909142, encodeId=6ac3909142bb, content=没有积分 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22475411922, createdName=ms9000001633000472, createdTime=Fri Dec 18 16:18:20 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914435, encodeId=c1869144356f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Thu Jan 07 16:25:46 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2021-05-08 ms7000001080466052

    学到了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1220084, encodeId=72bf122008477, content=英文 看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83dd8166609, createdName=ms1000001987466727, createdTime=Mon May 16 19:22:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963713, encodeId=47ec963e13f8, content=没积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/05735cbd2c774b54b63d3351c859e96a/e3534dc2feb14208afd8fe5875b5980b.jpg, createdBy=48af5495416, createdName=ms7000001080466052, createdTime=Sat May 08 14:03:02 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963712, encodeId=0cf3963e12cb, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/05735cbd2c774b54b63d3351c859e96a/e3534dc2feb14208afd8fe5875b5980b.jpg, createdBy=48af5495416, createdName=ms7000001080466052, createdTime=Sat May 08 14:02:58 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909142, encodeId=6ac3909142bb, content=没有积分 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22475411922, createdName=ms9000001633000472, createdTime=Fri Dec 18 16:18:20 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914435, encodeId=c1869144356f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Thu Jan 07 16:25:46 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2020-12-18 ms9000001633000472

    没有积分

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1220084, encodeId=72bf122008477, content=英文 看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83dd8166609, createdName=ms1000001987466727, createdTime=Mon May 16 19:22:41 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963713, encodeId=47ec963e13f8, content=没积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/05735cbd2c774b54b63d3351c859e96a/e3534dc2feb14208afd8fe5875b5980b.jpg, createdBy=48af5495416, createdName=ms7000001080466052, createdTime=Sat May 08 14:03:02 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963712, encodeId=0cf3963e12cb, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/05735cbd2c774b54b63d3351c859e96a/e3534dc2feb14208afd8fe5875b5980b.jpg, createdBy=48af5495416, createdName=ms7000001080466052, createdTime=Sat May 08 14:02:58 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909142, encodeId=6ac3909142bb, content=没有积分 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22475411922, createdName=ms9000001633000472, createdTime=Fri Dec 18 16:18:20 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914435, encodeId=c1869144356f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3e25414385, createdName=ms2000000057946177, createdTime=Thu Jan 07 16:25:46 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2021-01-07 ms2000000057946177

    学习了

    0

Baidu
map
Baidu
map
Baidu
map